Using cell line HH as a model and resource to reveal novel genomic rearrangements driving gene deregulation in CTCL, we identified overexpressed NFKB1 and RBPJ. This evidence concerns the gene RBPJ and primary cutaneous T-cell non-Hodgkin lymphoma.